NADH:ubiquinone oxidoreductase core subunit S8 expression and functional significance in non-small cell lung cancer
Open Access
- 21 April 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-17
Abstract
Hyperfunctional mitochondria provide a growth advantage by supporting the energy-intensive processes essential for non-small cell lung cancer (NSCLC). NADH:ubiquinone oxidoreductase core subunit S8 (NDUFS8) is a key subunit of mitochondrial complex I involved in oxidative phosphorylation (OXPHOS) and cellular energy production. Bioinformatics and local tissue examinations show that NDUFS8 expression is elevated in NSCLC compared to normal lung tissue. Both immortalized and primary human NSCLC cells exhibit higher NDUFS8 levels. Single-cell RNA sequencing confirmed NDUFS8 upregulation in cancerous cells of NSCLC tumor. Silencing NDUFS8 via shRNA or Cas9/sgRNA-mediated knockout (KO) disrupted mitochondrial functions, leading to decreased complex I activity, ATP depletion, mitochondrial depolarization, increased reactive oxygen species (ROS) production, and heightened lipid peroxidation. Furthermore, NDUFS8 silencing/KO triggered apoptosis and significantly reduced Akt-mTOR activation, cell viability, proliferation, and motility in various NSCLC cells. In contrast, ectopic overexpression of NDUFS8 boosted mitochondrial complex I activity and ATP levels, promoting Akt-mTOR activation, and enhancing NSCLC cell proliferation and motility. NDUFS8 also contributes to radioresistance in NSCLC; silencing or KO enhanced ionizing radiation (IR)-induced cytotoxicity, while overexpression mitigated it. Intratumoral injection of NDUFS8 shRNA-expressing adeno-associated virus significantly inhibited growth of primary NSCLC xenografts in nude mice, with observed NDUFS8 silencing, ATP reduction, oxidative damage, proliferation inhibition, Akt-mTOR inactivation and apoptosis in treated tissues. These findings highlight the pivotal pro-tumorigenic role of NDUFS8 in NSCLC.Keywords
This publication has 61 references indexed in Scilit:
- Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectivesCritical Reviews in Oncology/Hematology, 2021
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung CancerJAMA, 2019
- Mitochondria, Bioenergetics and Apoptosis in CancerTrends in Cancer, 2017
- PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challengesCancer Letters, 2017
- Mitochondria and CancerCell, 2016
- Targeting PI3K/AKT/mTOR pathway in non small cell lung cancerBiochemical Pharmacology, 2014
- Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLCCancer Treatment Reviews, 2014
- Human mitochondrial RNA polymerase: Structure–function, mechanism and inhibitionBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2012
- Mitochondrial Electron Transport Chain Complex III Is Required for Antimycin A to Inhibit AutophagyChemistry & Biology, 2011
- Mitochondrial RNA Polymerase Is Needed for Activation of the Origin of Light-Strand DNA ReplicationMolecular Cell, 2010